Characterization of two dominant alleles of the major rhodopsin-encoding gene ninaE in Drosophila by Mitra, Amitavo et al.
Characterization of two dominant alleles of the major rhodopsin-
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Purpose: In this study we investigated the biochemical and cell biologic characteristics of flies expressing two novel
dominant alleles of the major rhodopsin encoding gene neither inactivation nor afterpotential E (ninaE) in a heterozygous
background.
Methods: Presence of the deep pseudopupil in flies was assayed 5 days post eclosion. For structural analysis, 1-μm-retinal
cross sections were obtained from fixed and resin-embedded Drosophila heads. Confocal microscopy was performed on
dissected retinas stained with antibodies specific for rhodopsin, NinaA, and F-actin. Rhodopsin levels were determined
by western and slot blot analysis.
Results:  Dominant  rhodopsin  mutants  showed  progressive  age-dependent  and  light-independent  loss  of  the  deep
pseudopupil, without any apparent retinal degeneration at the morphological level. Expression of mutant rhodopsin caused
rhodopsin to mislocalize to the cell body and the endoplasmic reticulum compartment. Mutant rhodopsin also caused loss
of  solubility  of  wild-type  rhodopsin  and  its  accumulation  presumably  as  a  high  molecular  mass  complex  in  the
photoreceptor cell body.
Conclusions: In heterozygous mutant flies, there is loss of wild-type rhodopsin immunoreactivity on a western assay but
less reduction using slot blot analysis. This suggests that mutant rhodopsin is likely inducing the misfolding and insolubility
of wild-type rhodopsin. Localization of rhodopsin revealed that in mutant flies, wild-type rhodopsin is mislocalized to the
cell body and the endoplasmic reticulum.
Retinitis  pigmentosa  (RP)  is  a  diverse  collection  of
genetically inherited diseases that is characterized by loss of
visual acuity and retinal degeneration in humans [1-3]. The
heterogeneity of the disease can be appreciated by the fact that
RP  can  be  inherited  as  an  autosomal  dominant  (ADRP),
autosomal  recessive,  or  X-linked  disease  [4].  Despite  the
multimodal inheritance pattern, ADRP accounts for almost a
quarter of all cases of RP [5,6]. Mutations in the rhodopsin
gene account for the majority or most the underlying genetic
determinants of ADRP cases in worldwide surveys [7-10],
thus making the study of rhodopsin physiology in the context
of  RP  an  important  avenue  in  elucidating  the  molecular
mechanisms of RP. Despite the fact that mutations in a single
gene  (rhodopsin)  are  responsible  for  most  cases  of  RP,
mechanistic details might be complicated since in some cases
not only does the same mutation in different people exhibit
variability with respect to severity of their disease but also
different amino acid substitutions at the same position can lead
to distinct phenotypes [11,12].
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The  Drosophila  phototransduction  pathway  has  been
studied in detail and has been established as a model system
to elucidate mechanisms of retinal degeneration [13-15]. Even
though  the  vertebrate  and  Drosophila  phototransduction
cascades have a different organization, they share anatomic
and molecular features, making Drosophila an appropriate
model. The Drosophila eye is a compound eye that consists
of about 800 individual repeating units known as ommatidia.
Individual ommatidia have about 20 cells out of which eight
are photoreceptor cells. The phototransduction machinery in
photoreceptor  cells  is  localized  to  actin-rich  microvillar
structures  known  as  rhabdomeres  that  are  functionally
equivalent to vertebrate outer segments. Loss of individual
rhabdomeres  within  photoreceptors  and/or  the  loss  of  the
ommatidial array are indicative of retinal degeneration. The
vertebrate  and  invertebrate  light-stimulated  signal
transduction pathways are thematically similar, as evidenced
by several common proteins [13,16].
Numerous  rhodopsin  mutations  were  isolated  in
Drosophila screens in the late 1960s [17-20], many of which
cause retinal degeneration in fly photoreceptors. In a more
recent screen, dominant neither inactivation nor afterpotential
E (ninaE) alleles that undergo retinal degeneration have been
isolated, some of which correspond to mutations in the same
residues of human rhodopsin associated with ADRP [21].
Relevance  for  a  Drosophila  model  of  RP  was  further
established  when  it  was  found  that  the  most  frequently
occurring mutation in ADRP, a proline substitution at position
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322423  by  histidine,  faithfully  recapitulated  the  dominant
degenerative  phenotype  when  engineered  into  the
Drosophila rhodopsin gene [22].
Quantification of the rhodopsin present in such mutant
flies, especially for rhodopsin mutants, is a widely used assay
in all studies, but the lack of any detailed insight into the fate
of  rhodopsin  has  led  to  questioning  how  low  levels  of
rhodopsin lead to rhodopsin-mediated retinal degeneration.
The endoplasmic reticulum (ER) has been implicated to play
a role in ADRP [10,23], and only recently has the importance
of the accumulation of misfolded rhodopsin and its clearance
mechanism  been  elucidated  [24,25].  Accumulation  of
rhodopsin in photoreceptors, which potentially can be prone
to  aggregation  and/or  resistant  to  proper  maturation/
degradation, may contribute to the underlying mechanism(s)
of retinal degeneration in phototransduction mutants, which
otherwise show variability in functional and morphological
phenotypes.
In  this  study  we  report  two  new  alleles  of  the
Drosophila  major  rhodopsin  gene  (ninaE),  ninaER11  and
ninaER12. These two alleles are dominant and exert their effect
in a light-independent manner. Using a combination of cell
biologic  and  molecular  approaches,  we  describe
characteristics of these two novel alleles along with three
previously characterized alleles as a comparison. We show
that  in  heterozygous  mutant  flies,  there  is  a  significant
accumulation of rhodopsin, part of which may be mislocalized
to the cell body and the ER along with the disruption of the
ER pattern within the cell body of photoreceptors. Mutant
rhodopsin expression exerts its dominant effect by inducing
misfolding and insolubility of wild-type rhodopsin.
METHODS
Drosophila stocks: Drosophila melanogaster stocks ninaE5,
ninaED1, and ninaED2 were obtained from the Bloomington
stock center (Bloomington, IN). The ninaER11 and ninaER12
alleles  were  identified  in  a  previous  arrestin  2  (arr2)
degeneration enhancer screen [26]. All ninaE alleles were
crossed into a white (w1118) background, and progeny were
collected  that  were  haploid  for  mutant  and  wild-type
rhodopsin. Flies were reared in constant darkness.
Deep pseudopupil analysis: At least 15 flies of each genotype
were reared in complete darkness for 5 days and tested for the
presence of deep pseudopupil (DPP) at 24-h intervals. Flies
with a distinct DPP were given a score of 5; flies with faint to
diffuse DPP were given a score of 3; and flies with no DPP
were given a score of 0. The average of the observations was
reported as the DPP score of the fly population within each
genotype for each day.
Histological  fixation  and  sectioning:  Heads  of  flies  were
bisected and immersed in ice-cold 2% glutaraldehyde in 0.1
M  phosphate  buffer.  An  equal  volume  of  2%  osmium
tetroxide was added and incubated for 30 min on ice. The
glutaraldehyde/osmium tetroxide solution was removed, and
the eyes were washed with 0.1 M phosphate buffer, followed
by treatment with 2% osmium tetroxide for 60 min. The eyes
were then serially dehydrated with increasing ice-cold ethanol
(15%, 30%, 50%, 70%, and 90%) for 10 min each on ice. This
was followed by two 10-min incubation periods in 100%
ethanol at room temperature and two 10-min incubations in
propylene  oxide  (Electron  Microscopy  Sciences,  Hatfield,
PA). The heads were incubated in a 50% propylene oxide/50%
Durcupan  ACM  Fluka  (Sigma,  St.  Louis,  MO)  mixture
overnight on a rotator at room temperature, followed by a 4-
h incubation in 100% Durcupan. Eyes were then embedded in
100% Durcupan and cured at 70 °C overnight. Cross sections
(1  μm)  were  cut  using  a  Sorvall  ultra  microtome  MT-1
(Sorvall,  Newtown,  CT).  The  sections  were  stained  with
toluidine blue and observed on a Zeiss Axioplan 2 microscope
using  a  63×/2  numerical  aperture  (NA)  oil  immersion
objective. Digital images were captured using an Optronics
DEI-750 camera Optronics DEI-750 camera and associated
software (Carl Zeiss Optronics, Oberkochen, Germany). At
least three flies were analyzed for each genotype and treatment
paradigm.
Western and slot blot assay: Three fly heads of each genotype
were homogenized in 25 μl Laemmli 1× sodium dodecyl
sulfate  (SDS)  loading  buffer.  Each  lysate  (20  μl)  was
subjected to SDS PAGE (SDS–PAGE) followed by western
analysis  [26].  The  primary  antibodies  used  were  anti-
Rhodopsin1  (Rh1;  1:1,000;  Developmental  Studies
Hybridoma Bank, Iowa City, IA), anti-Rh1–1D4 (1:100,000;
gift from Dr. John Hwa, Weill Cornell Medical College, New
York,  NY),  anti-Rab7  (1:10,000)  [27],  and  anti-Arrestin2
(Arr2; 1:1,000). Secondary antibodies used were horseradish
peroxidase  (HRP)  conjugated  antimouse  or  antigoat
(1:5,000). Arr2 and Rab7 were used as loading controls.
Densitometric  analysis  of  Rh1,  Arr2,  and  Rab7  was
performed  using  the  BioRad  ImageQuant  software
(Amhersham Bioscience, Piscataway, NJ). Each experiment
was repeated independently three times.
For slot blot analysis, two wild-type heads were ground
in 20 μl 1× SDS loading buffer, and the total volume was
adjusted to 200 μl with 1× SDS loading buffer/1 M urea in
0.5× PBS (0.15 M NaCl, 0.002 M KCl, 0.01 M Na2HPO4,
0.001 M KH2PO4, pH 7.4). Serial dilutions were prepared, and
samples equivalent to 1, 0.5, 0.25, and 0.125 heads were
applied  to  a  BioDot  apparatus  (BioRad,  Hercules,  CA).
OptiTran  BA-S  85-supported  nitrocellulose  membrane
(Whatman, Piscataway, NJ) was used for the protein transfer.
For  heterozygous  mutants,  lysate  concentrations  were
doubled. The membrane was denatured by incubating in 0.2
M sodium hydroxide for 30 min at room temperature followed
by  blocking  in  5%  milk  in  1×  PBS+0.1%  Tween-20  for
another 30 min. Antibody incubations were performed as in
western analysis.
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3225Densitometric analysis of total Rh1 levels in wild-type
and mutant flies was performed as described for western blot
analysis. Total rhodopsin level in heterozygous mutant flies
relative  to  wild-type  flies  was  calculated  and  plotted  by
comparing  rhodopsin  levels  of  mutants  at  various
concentrations  to  those  of  wild-type  samples.  Rhodopsin
levels for each sample were arrived at by averaging the values
obtained from three independent repetitions.
Immunohistochemistry:  Retinas  from  adult  flies  were
prepared  for  whole-mount  immunostaining  as  described
previously [27]. The primary antibodies used were anti-Rh1
(1:50; Developmental Studies Hybridoma Bank, Iowa City,
IA), anti-Rh1–1D4 (1–800; a gift from Dr. John Hwa, Yale
University), anti-Rh1 (1:50; polyclonal antibody; gift from
Dr. C. Zuker, Columbia University, New York, NY), and anti-
NinaA (1:150; gift from Dr. Craig Montell, Johns Hopkins
University, Baltimore, MD). Rhabdomeres were visualized
by  staining  for  F-actin  using  rhodamine  or  Alexa-568-
conjugated  phalloidin  (Molecular  Probes,  Carlsbad,  CA).
Secondary  antibodies  were  antimouse-  or  antirabbit-
conjugated  Alexa-488  or  Alexa-647  (1:300;  Molecular
Probes).
Images were captured on a Leica TCS SP confocal laser-
scanning  microscope  (Leica  Microsystems,  Heidelburg,
Figure 1. Schematic of rhodopsin protein and location of mutations.
Yellow dots represent the position of previously published ninaE
alleles used in this study. Red dots represent novel alleles of ninaE.
The genetic change and corresponding allele names are as following:
P84L, ninaER11; S95F, ninaED2; P120L, ninaE5; S137F, ninaED1;
S177L, ninaER12.
Germany) and Nikon A1RSi Confocal Workstation (Nikon,
Melville,  NY).  Image  processing  was  done  with  Adobe
Photoshop (San Jose, CA). Retinas from at least three flies in
each genotype were processed.
Statistical analyses: The Student t test was used for statistical
comparison  between  wild-type  controls  and  the  various
mutant genotypes. Differences were considered statistically
significant at p<0.05.
RESULTS AND DISCUSSION
Progressive light-independent loss of the Deep Pseudopupil
in  ninaE  heterozygous  flies:  Previously,  we  isolated  a
collection of genetic enhancers of arr2 degeneration [26].
From that collection, two alleles were genetically mapped to
the ninaE locus, which encodes for the major Drosophila
rhodopsin, Rh1. Sequencing of the ninaE gene from these
alleles indicated that they both had point mutations within the
coding region. The ninaER11 allele has a proline to leucine
mutation in the first cytoplasmic loop at position 84, and the
ninaER12 allele has a serine to isoleucine mutation in the fourth
transmembrane domain at position 177 (Figure 1).
Since  ADRP  accounts  for  the  majority  of  cases  of
diagnosed RP, we are primarily interested in the dominant
phenotype exerted by the mutant protein on its wild-type
counterpart.  To  test  whether  these  rhodopsin  alleles  had
dominant phenotypes, we reared heterozygous ninaE mutant
Figure  2.  Heterozygous  ninaE  mutants  show  loss  of  deep
pseudopupil. At least 15 newly eclosed ninaER11/+ and ninaER12/+
flies were reared in the dark for 5 days and deep pseudopupil (DPP)
was assayed once per day. A graded scoring system was used wherein
scores of 5, 3, or 0 were given to flies with intact, diffuse, or absent
DPP, respectively. Note the age-dependent gradual loss of DPP in
heterozygous mutant flies. The DPP loss in both ninaER11/+ and
ninaER12/+ flies is statistically significant for all time points (p<0.05).
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3226flies in complete darkness and assayed them for loss of the
DPP [28]. The DPP is a virtual image of the trapezoidal array
of multiple rhabdomeres near the center of curvature of the
Drosophila compound eye [29]. The loss of the DPP indicates
a reduction in the amount of rhodopsin or a disruption in the
ommatidial  structure.  Both  ninaER11/+  and  ninaER12/+  flies
reared in the dark underwent progressive loss of DPP, with
only about 10% of flies showing no loss of DPP by day 5 post
eclosion (Figure 2). The loss of DPP in mutant heterozygous
flies  compared  to  control  flies  for  every  time  point  is
significant with a p value less than 0.05. Although a small
number of flies retained their DPP at the end of our assay time
frame, the data clearly showed the trend of loss of the DPP in
a  light-independent  manner.  The  continued  presence  of
detectable DPP in a minor percentage of flies is likely due to
the qualitative basis of the DPP assay and/or variation in the
phenotype presentation within the fly population at the time
of our assay. These data suggest that ninaER11 and ninaER12 are
dominant alleles of ninaE and that the loss of DPP is age
dependent  and  light  independent,  suggesting  underlying
retinal degeneration.
Rhabdomeres  of  the  mutants  do  not  degenerate:  Since
heterozygous mutant flies show loss of DPP, we examined
aged flies to observe the loss of rhabdomeres and/or loss of
structural integrity of the ommatidial array. Flies aged for 3
weeks  in  complete  darkness  did  not  show  any  readily
identifiable  hallmarks  of  degeneration  and  had  a  full
complement of seven rhabdomeres per ommatidium and a
regular ommatidial array (Figure 3A-C). Moreover, analysis
of heterozygous animals reared in a 12 h:12 h light–dark cycle
for up to 30 days showed minimal changes in photoreceptor
cell structure and rhabdomere morphology (Figure 3D-F).
These results are also consistent with previous reports on
published ninaE alleles. It should be noted that the previously
identified ninaED1 dominant allele showed degeneration only
when  exposed  to  continuous  light  and  showed  minimal
degeneration in dark-reared flies only after 40 days [30]. We
also analyzed ninaER11 and ninaER12 homozygous flies under
two different aging paradigms (7-day and 3-weeks old, dark
reared) by means of cross sections and did not observe any
noticeable retinal degeneration (data not shown).
The lack of major structural defects is not necessarily in
conflict with the observed early loss of DPP data. It has been
Figure 3. Heterozygous ninaE mutants maintain rhabdomeric integrity. Flies in panels (A-C) were processed 21 days post eclosion and reared
in constant darkness at room temperature. Flies in panels (D-F) were processed 30 days post eclosion and reared in 12 h:12 h light–dark cycles.
Note the distinct presence of rhabdomeres in the heterozygous mutant photoreceptors in both regimens.
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3227previously shown that the loss of DPP can be correlated to
reduced rhodopsin content even when the photoreceptors have
intact rhabdomeres [29,31]. Moreover, although rhodopsin is
required for photoreceptor morphogenesis and viability [32,
33],  it  has  been  previously  shown  that  flies  with  a  70%
reduction  in  photopigment  level  [34]  or  a  reduction  in
rhodopsin  levels  to  <3%  in  photoreceptors  [35]  have  an
overall normal photoreceptor morphology.
Three mutations in the human rhodopsin gene have been
identified  that  cause  congenital  stationary  night  blindness
[36-38]. In this form of retinopathy, similar to RP, loss of
vision in low-light conditions is an early clinical observation,
but unlike RP where there is a prominent loss of rods and
cones, in congenital stationary night blindness there is no loss
of rods and cones. These histological results are similar to
those observed in the Drosophila mutants in this study as no
loss of rhabdomeres in photoreceptor cells was observed.
Rhodopsin  is  mislocalized  in  dominant  mutants:  Our
histological data indicate that in mutant photoreceptors low
levels  of  rhodopsin  may  be  properly  trafficked  to  the
rhabdomeres  to  maintain  rhabdomeric  integrity.  To  test
whether rhabdomeric rhodopsin is present in these flies and
whether there is any mislocalization of rhodopsin, we stained
whole retinas with anti-Rh1 and the ER-specific marker anti-
NinaA. The ninaA gene in the Drosophila genome encodes
for  an  eye-specific  homolog  of  cyclosporine  A-binding
protein [39], which functions as an Rh1-specific chaperone
and is involved in its maturation and transport from the ER to
the rhabdomeric membranes [40-42]. We wanted to ascertain
if, in our mutants, rhodopsin is localized to the ER, indicating
maturation/trafficking defect/delay.
In dark-reared wild-type flies, Rh1 is localized to the base
of rhabdomeres in a crescent-like shape and no cytoplasmic
rhodopsin  can  be  observed  (Figure  4C).  NinaA  shows  a
diffused staining pattern throughout the cell body (Figure 4B).
Figure 4. Rhodopsin and NinaA show improper localization in heterozygous ninaE mutants. Dark-reared fly retinas were isolated and triple
stained for F-actin, Rhodopsin (Rh1), and neither inactivation nor afterpotential protein (NinaA). A-D: Wild-type photoreceptors show proper
rhodopsin localization to the base of the rhabdomeres and NinaA is localized to the cell body. E-H: ninaER11/+ photoreceptors show partial
proper rhodopsin localization with multiple rhodopsin- and ninaA-positive puncta present in the cell body. NinaA staining is restricted to the
edges of the cell body. I-L: ninaER12/+ photoreceptors show rhodopsin localization to the base of the rhabdomeres, with diffuse rhodopsin
staining in the cell body having few distinct rhodopsin-positive vesicles. NinaA stains diffusely throughout the cell body similar to the wild
type. Scale bar represents 5 μm.
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3228Figure 5. Quantification of soluble and total rhodopsin in heterozygous ninaE mutants. A: Lysates equivalent of four heads were loaded onto
a sodium dodecyl sulfate PAGE (SDS–PAGE) gel and probed with anti-Rh1 antibody, while Rab7 antibody was used as a loading control for
western analysis. B: Whole head lysates equivalent to two wild-type heads and four heterozygous mutant heads were prepared and diluted for
slot blot analysis as detailed in the Methods and probed with anti-Rh1 antibody. C: The blots probed with anti-Rh1 antibody were quantified
to reflect the relative level of soluble versus total rhodopsin in mutant flies. Note the loss of wild-type rhodopsin intensity in (C) when mutant
rhodopsin is co-expressed in the same photoreceptors. The difference in the levels of soluble versus total rhodopsin in each of the genotypes
tested is statistically significant (p<0.014). Error bars are represented as average % Rhodopsin±SD. Each column represents the average of
three biologic replicates.
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3229Figure 6. Wild-type rhodopsin quantification and localization in heterozygous ninaE mutants expressing rhodopsin with a 1D4 monoclonal
antibody tag (Rh1-ID4). A: Lysates equivalent of one head were loaded onto each lane and probed with anti-Rh1–1D4 antibody that specifically
recognizes wild-type protein. Arrestin2 was used as the loading control. B: The blot probed with anti-Rh1–1D4 antibody was quantified to
show levels of rhodopsin in mutants relative to the wild type. The reduction in levels of soluble wild-type rhodopsin in heterozygous mutant
flies is significant compared to controls (p<0.0001). C-E: Dark-reared fly retinas were isolated and stained for F-actin and Rh1–1D4. Wild-
type photoreceptors show proper rhodopsin localization to the base of the rhabdomeres. F-H: Flies expressing non-1D4-tagged rhodopsin (+/
+) show no staining for rhodopsin, highlighting the specificity of the antibody. I-K: Flies haploid for mutant ninaER11 and wild-type Rh1–
1D4 show partial proper rhodopsin localization with significant rhodopsin-positive puncta mislocalized to the cell body. Error bars are
represented as average % rhodopsin±SD. Each column represents the average of three biologic replicates. Scale bar represents 5 μm.
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3230All  mutant  photoreceptors  show  some  rhabdomeric
localization of rhodopsin, suggesting that some proportion of
rhodopsin may be correctly trafficked to its site of activity.
This  rhabdomeric  rhodopsin  may  explain  the  long  term
viability of photoreceptors and lack of morphological defects.
However,  both  mutants  analyzed  exhibit  some  defect  in
rhodopsin  localization  where  a  significant  amount  is
mislocalized to the cell body.
In  ninaER11/+  flies,  a  proportion  of  rhodopsin  is
mislocalized in a punctate-staining pattern in the cell body.
Many  of  the  large  rhodopsin-positive  puncta  also  stain
positive for NinaA. In contrast to NinaA distribution in wild-
type flies, NinaA in ninaER11/+ is limited to the cell body
periphery and is no longer localized throughout the cell body
(Figure 4E-H). Flies heterozygous for the ninaER12 mutation
show extensive diffused rhodopsin mislocalization to the cell
body that does not seem to localize with NinaA. In contrast,
NinaA is localized in a wild-type distribution (Figure 4I-L).
As we use NinaA as a marker for the ER, we speculate, based
on the restrictive ER staining in ninaER11 heterozygous flies,
that the normal ER distribution within photoreceptor cells in
a  mutant  background  may  be  affected.  Another  mutually
nonexclusive possibility is that the majority of the NinaA is
relocated within the ER to areas where rhodopsin is present
and  likely  concentrated.  We  see  similar  results  with  the
previously published dominant ninaE allele ninaED2 (data not
shown). We also see normal NinaA distribution in another
previously published dominant ninaE allele ninaED1 (data not
shown);  this  distribution  is  similar  to  our  observations  in
ninaER12/+ flies. This suggests that there exists heterogeneity
within the dominant ninaE alleles in presentation of defects
at  the  cellular  level.  This  collection  of  data  suggests  that
rhodopsin is mislocalized to the cell body and may also be
accumulating  in  the  ER,  resulting  in  changes  in  the  ER
distribution pattern and/or localization of NinaA within the
ER.
Rhodopsin  becomes  insoluble  in  mutant  photoreceptors:
Previously it has been shown that mutations in rhodopsin
cause a reduction in protein levels. When protein levels are
determined  by  western  blot  analysis,  ninaER11/+  and
ninaER12/+ show significantly (10% [p<0.0001] and about 6%
[p<0.001], respectively) rhodopsin levels relative to the wild
type (Figure 5A,C). Since all of the animals analyzed were
heterozygous and contained a haploid content of wild-type
rhodopsin, the loss of rhodopsin immunoreactivity below 50%
indicates that the mutant rhodopsin is triggering the loss of
rhodopsin in this assay.
In human cases of ADRP, mutant rhodopsin has been
shown to be prone to aggregation and to form high molecular
weight complexes [43]. Abnormal accumulation of protein
aggregates is also associated with diverse human pathologies,
such  as  Huntington’s  disease,  Alzheimer  disease,  and
spinocerebellar ataxia [44]. Therefore, we explored whether
rhodopsin becomes insoluble in the dominant mutants. We
reasoned that insoluble aggregated rhodopsin might not be
detectable on immunoblots since the protein complexes may
be unable to enter the polyacrylamide gel matrix. However,
insoluble proteins may be detectable by slot blot analysis since
this method does not require the proteins to be solublized.
Interestingly, slot blot data indicate that there is significantly
more rhodopsin in the dominant mutants than detected by
western  blot.  Flies  heterozygous  for  the  ninaER11  and
ninaER12 mutations show approximately twofold to fourfold
more total rhodopsin than on western blots. These differences
are statistically significant (p<0.001; Figure 5B,C). This is
also evident in the immunolocalization data in Figure 4. Even
though there is no detectible protein on a western blot, both
ninaER11  and  ninaER12  heterozygotes  exhibit  Rh1
immunoreactivity. In the case of ninaER12, levels appear even
higher than the wild type.
We  were  interested  in  whether  other  previously
characterized  rhodopsin  alleles  also  show  a  difference
between soluble (western blot) and total (slot blot) rhodopsin
levels. We chose to analyze ninaED1, ninaED2, and ninaE5
alleles (Figure 1). Similar to the ninaE11 and ninaE12 alleles in
this study, these rhodopsin mutations have previously been
shown to induce low levels of rhodopsin on western blots and
minimal retinal degeneration [30]. ninaED1/+ and ninaED2/+
flies  show  a  significant  severe  loss  of  rhodopsin
immunoreactivity on a western blot, less than 10% of wild-
type levels (p<0.0001; Figure 5A, C). This is comparable to
previously described rhodopsin levels in these two mutants
[30]. We have found that ninaE5/+ flies exhibit approximately
15% rhodopsin levels (p<0.001) compared to about 1.5% in
ninaE5/+ flies relative to the wild type, as reported elsewhere
[45] (Figure 5A,C).
However, using slot blot analysis, there is a significant
sixfold  (p<0.001)  and  15-fold  (p<0.05)  more  detectable
rhodopsin in ninaED1/+ and ninaED2/+ flies, respectively, while
ninaE5/+  shows  about  threefold  (p<0.05)  more  rhodopsin
compared  to  wild-type  levels  (Figure  5B,C).  These  data
suggest that rhodopsin in dominant ninaE alleles may not be
efficiently degraded, and instead much of the rhodopsin may
still be present in a form that is resistant to solubility. The data
also suggest that western blot analysis may not be sufficient
to  detect  proteins  that  are  prone  to  aggregate,  and  other
methods that do not require protein solubilization should be
used.
Mutant rhodopsin forces the loss of immunoreactivity and
mislocalization of wild-type rhodopsin: Our biochemical data
indicates that there is a loss of both wild-type and mutant
rhodopsin in the heterozygous flies. To establish that mutant
rhodopsin expression specifically induces loss of wild-type
rhodopsin  immunoreactivity,  we  expressed  epitope-tagged
rhodopsin in the presence of the rhodopsin variant. We took
advantage  of  a  variant  of  Rh1  where  the  C-terminus  of
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terminus  [46].  A  monoclonal  antibody,  ID4,  specifically
recognizes  the  C-terminus  of  bovine  rhodopsin  [47]  and
therefore  will  recognize  tagged  rhodopsin  (1D4)  but  not
endogenous rhodopsin (+/+; Figure 6A, lane 1; Figure 6F-H).
In  this  way  we  can  monitor  the  presence  of  wild-type
rhodopsin independently from mutant rhodopsin.
When  ID4-tagged  wild-type  rhodopsin  (Rh1–1D4)  is
expressed along with mutant rhodopsin, there is a significant
decrease in immunoreactivity of tagged wild-type rhodopsin.
The decrease in immunoreactivity on immunoblots closely
parallels the data observed when all Rh1 is analyzed (Figure
6A).  Compared  to  flies  expressing  Rh1–1D4  alone,  we
detected  16.6%  rhodopsin  in  flies  of  ninaER11/Rh1–1D4
(p<0.01),  5%  in  ninaER12/Rh1–1D4  (p<0.0001),  13.5%  in
ninaED1/Rh1–1D4 (p<0.01), and 5.4% in ninaED2/Rh1–1D4
(p<0.0001;  Figure  6B).  This  loss  of  wild-type  rhodopsin
indicates that mutant rhodopsin is specifically triggering the
loss of immunoreactivity of wild-type rhodopsin in this assay.
Since we have demonstrated that mutant rhodopsin is
forcing the loss of solubility, which is likely due to misfolding
of wild-type rhodopsin, we predicted that wild-type rhodopsin
is also mislocalized in the mutant photoreceptors. We chose
to look at ninaER11/+ flies specifically as we had observed
multiple Rh1-positive puncta in the cell body of dark-reared
animals. Immunolocalization data demonstrate that there are
significantly  more  wild  type  Rh1–1D4-positive  vesicles
mislocalized to the cell body compared to haploid Rh1–1D4
flies alone (Figure 6C-E, I-K). We were unable to perform slot
blots  using  the  1D4  antibody,  as  is  shown  in  Figure  5.
However, even though there are severely reduced levels of
Rh1 on western blots for ninaER11/Rh1–1D4 animals, there are
detectable levels using immunofluorescence, indicating that
Rh1 is still present but is in a conformation that cannot be
revealed using western analysis.
Overall,  our  data  indicate  that  mutant  rhodopsin
expression  exerts  its  dominant  effect  by  inducing
mislocalization and insolubility of wild-type rhodopsin. This
results in the likely impaired clearance and accumulation of
rhodopsin that may underlie the cause of cell death.
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